Key Metrics
9.4
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.001 - 0.005
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.9
5-Year SI
5-year SI
- N/A 2-year SI
- 0.9 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Immunology
SJR
- Q1 Immunology
- Q1 Pharmacology
- Q1 Infectious Diseases
- Q1 Pharmacology (medical)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.99
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
6 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Virus
- Antibody response
- Pneumonia
- Env Protein
- Immunization
- Hematopoietic stem cell transplantation
- Mucosal vaccine
- Serotype
- Polio vaccine
- Bordetella pertussis
- Guinea pig
- H1N1 influenza
- Alum
- Nipah virus
- Lethal dose
- Virus vaccine
- Immunotherapy
- Malaria vaccine
- Neutralizing antibody
- Lymph node
Journal Specifications
| Overview | |
| Publisher | NATURE PORTFOLIO |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 3190 | USD 3490 | GBP 2790 |
| Publication Time | 11 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Sealy Center for Vaccine Development at the University of Texas Medical Branch |
| Frequency | Continuous publication |
| Publication Start Year | 2015 |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 11 |
| Article Processing Charges | EUR 3190 | USD 3490 | GBP 2790 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
Planning to publish in npj Vaccines ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
A therapeutic Porphyromonas gingivalis gingipain vaccine induces neutralising IgG1 antibodies that protect against experimental periodontitis.
- 1 Dec 16
- NPJ vaccines
-
Full paper
An efficient cell free enzyme-based total synthesis of a meningococcal vaccine candidate.
- 15 Nov 16
- NPJ vaccines
-
Full paper
Zika vaccine candidates progress through nonclinical development and enter clinical trials.
- 10 Nov 16
- NPJ vaccines
-
Full paper
In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine.
- 10 Nov 16
- NPJ vaccines
-
Full paper
Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague.
- 13 Oct 16
- NPJ vaccines
-
Full paper
A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice.
- 22 Sep 16
- NPJ vaccines
Scite analysis
Powered by scite_
873 articles received 14.7k citations see all
- 479 Supporting
- 14,029 Mentioning
- 50 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 38 Corrections
- 30 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
4%
4 to 6 months
40%
7 to 9 months
35%
Above 9 months
21%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has npj Vaccines been actively publishing?
npj Vaccines has been in operation since 2015 till date.
What is the publishing frequency of npj Vaccines ?
npj Vaccines published with a Continuous publication frequency.
How many articles did npj Vaccines publish last years ?
In 2023, npj Vaccines published articles.
What is the eISSN & pISSN for npj Vaccines ?
For npj Vaccines,eISSN is 2059-0105 and pISSN is2059-0105.
What is Citescore for npj Vaccines ?
Citescore for npj Vaccines is 9.4.
What is SNIP score for npj Vaccines ?
SNIP score for npj Vaccines is 1.99.
What is the SJR for npj Vaccines ?
SJR for npj Vaccines is Q1.
Who is the publisher of npj Vaccines ?
NATURE PORTFOLIO is the publisher of npj Vaccines.